Key facts
- A mother is calling for ketamine to be classified as a Class A drug.
- Her daughter, Isabelle Sapherson-Moralee, died in April 2025 at the age of 22.
- Isabelle Sapherson-Moralee had been taking ketamine for five years.
Mother calls for ketamine to be Class A drug after daughter's death
IN SHORT
A grieving mother is advocating for ketamine to be reclassified as a Class A drug following the death of her 22-year-old daughter, Isabelle Sapherson-Moralee, who had battled addiction for five years.
Key Numbers
22age of daughter at death
April 2025date of daughter's death
5 yearsduration of ketamine use
5st 9lbdaughter's weight at death
39kgdaughter's weight at death
Who's Involved
Isabelle Sapherson-Moralee
22-year-old who died after a battle with ketamine addiction
Mother of Isabelle Sapherson-Moralee
advocating for ketamine reclassification to Class A drug
↳ Why This Matters
This advocacy highlights concerns about the potential harms of ketamine use and addiction, potentially influencing drug policy and public health approaches to substance abuse.